Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thymoma × Bupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Pain, Postoperative 2 Breast Neoplasms 2 Agnosia 2 Vesico-Ureteral Reflux 1 Ureteral Neoplasms 1 Thymoma 1 Nephrolithiasis 1 Lymphedema 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyoma 1 Laparoscopic Surgery 1 Kidney Neoplasms 1 Duodenal Neoplasms 1 Cerebrovascular Disorders 1

Interventions

Radiotherapy 3 pembrolizumab 2 Drug Therapy 2 zimberelimab 1 lenvatinib 1 fludarabine 1 Thymectomy 1 Thoracic Surgery, Video-Assisted 1 Radiotherapy, Adjuvant 1 Proton Therapy 1 Paclitaxel 1 Methylprednisolone 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Etoposide 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06545409 2025-03-25

SPRATS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡